Medtronic reports first quarter fiscal 2024 financial results

Broad strength across businesses and geographies results in mid-single digit revenue growth, driven by execution, innovation, and improved underlying fundamentals dublin , aug. 22, 2023 /prnewswire/ -- medtronic plc (nyse:mdt) today announced financial results for its first quarter of fiscal year 2024 (fy24), which ended july 28, 2023. key highlights revenue of $7.7 billion increased 4.5% as reported and 6.0% organic gaap diluted earnings per share (eps) of $0.59 decreased 16%; non-gaap diluted eps of $1.20 increased 6% company increases fy24 organic revenue growth and eps guidance commenced u.s. launches of the minimed™ 780g system with guardian™ 4 sensor in diabetes and the micra™ av2 and micra™ vr2 leadless pacemakers in cardiovascular financial results medtronic reported q1 worldwide revenue of $7.702 billion, an increase of 4.5% as reported and 6.0% on an organic basis.
MDT Ratings Summary
MDT Quant Ranking